Gemfibrozil

Article Details

Citation
Copy to clipboard

Quintanilla Rodriguez BS, Correa R

Gemfibrozil

.

PubMed ID
31424850 [ View in PubMed
]
Abstract

Gemfibrozil is an FDA approved fibric acid agent (fibrate) for the management of hypertriglyceridemia (particularly in type IV and V hyperlipidemia). Diet and exercise constitute the first-line treatment for mild and moderate hypertriglyceridemia. However, patients with no adequate therapeutic response to dietary measurements will benefit from the initiation of this medication. Very high levels of triglycerides represent a risk factor for the development of acute pancreatitis. Gemfibrozil is a useful medication for the reduction of triglycerides in patients with a very high triglycerides serum levels.

DrugBank Data that Cites this Article

Drugs